pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,878 catalysts · 4,876 phase readout · 2,367 8k filing · 286 earnings · 275 pdufa · 149 phase 2 completion · 66 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 0 catalysts2026-07-23: 0 catalysts2026-07-24: 0 catalysts2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×type: phase readout×clear all
type
  • phase readout4,876
  • 8k filing2,367
  • earnings286
  • pdufa275
  • phase 2 completion149
  • phase 1 completion66
phase 2 initiation
41
  • phase 1 initiation39
  • phase 1 2 completion31
  • phase 0 trial completion22
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›COMPLETEDphase readoutNCT07433231: Magnesium Sulfate Versus Other Anesthesia Drugs to Reduce Agitation After Adenotonsillectomy in Pediatric Patients

    Sponsor: Ayfer Kaya Gök. Phase: NA. Conditions: Anesthesia Emergence Delirium, Adenotonsillar Hypertrophy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07611331: Single-Layer Versus Double-Layer Uterine Closure After Primary Cesarean Section

    Sponsor: Hédi Chaker Hospital. Phase: NA. Conditions: Cesarean Scar Defect (Isthmococele), Pelvic Pain, Spotting, Amenorrhea Secondary, Metrorrhagia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07089953: Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomized Controlled Trial (EHR Study #3)

    Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Communication Skills, Professionalism, Randomized Controlled Trial, Perception

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03083353: Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation

    Sponsor: Jasper A. Smits. Phase: EARLY_PHASE1. Conditions: Nicotine Dependence, Smoking, Cigarette, Smoking Cessation, Smoking Behaviors, Smoking Reduction, Craving

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05093153: Spanish Registry of Patients With IgM Monoclonal Gammopathies

    Sponsor: Fundación Española de Hematología y Hemoterapía. Phase: . Conditions: Waldenstrom Macroglobulinemia

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05650853: Exploration of eJaculatory Anatomy Concept Study (EJAC Study)

    Sponsor: Clinique Pasteur. Phase: NA. Conditions: Ejaculatory Dysfunction

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07588737: Multimodal AI-Guided Recovery Management After Lung Cancer Surgery

    Sponsor: The First Affiliated Hospital of Guangzhou Medical University. Phase: NA. Conditions: Postoperative Care, Rehabilitation, Artificial Intelligence (Al), Randomized Controlled Trial (RCT)

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07530237: Efficacy of Periarticular Vasoconstrictor Infiltration (PVI) in Reducing Bleeding and Postoperative Pain in Lumbar Fusion Surgery

    Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau. Phase: . Conditions: Intraoperative Bleeding in Lumbar Spine Surgery, Postoperative Pain in Lumbar Spine Surgery

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07587437: Preoperative Use of a Magnetically Controlled Capsule Endoscopy in Patients Undergoing Bariatric Surgery

    Sponsor: Jerry Dang. Phase: NA. Conditions: Obesity, Bariatric Surgery Candidate, Hypertension, Diabetes

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05751837: Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal Tumors

    Sponsor: Patrick Wagner, MD, FACS. Phase: PHASE1. Conditions: Abdominal Cancer, Malignancy

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05895929: The Role of IL5 in Epithelial Cell Integrity

    Sponsor: Johns Hopkins University. Phase: EARLY_PHASE1. Conditions: Chronic Rhinosinusitis With Nasal Polyps, Chronic Rhinosinusitis (Diagnosis)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07582731: A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease

    Sponsor: Jie Liang. Phase: NA. Conditions: Inflammatory Bowel Diseases

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06118931: Time-restricted Eating, Window Timing, Type 2 Diabetes Status and Sex on Glycemic Control

    Sponsor: University of Toronto. Phase: NA. Conditions: Diabetes Mellitus, Type 2, Obesity, Prediabetic State, Hyperglycemia

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07470502: MICI-BIO: Study on Patient With Chronic Inflammatory Bowel Disease

    Sponsor: Meyer Children's Hospital IRCCS. Phase: NA. Conditions: IBD (Inflammatory Bowel Disease)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04368702: CONFIRM: Magnetic Resonance Guided Radiation Therapy

    Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Gastric Cancer, Invasive Breast Cancer, in Situ Breast Cancer, Mantle Cell Lymphoma, Larynx Cancer, Bladder Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07379502: Endometrial Response in Polycystic Ovarian Syndrome Treated With Letrozole Alone or With Added Estradiol Valerate

    Sponsor: CMH Kharian Medical College. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07491445: Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

    Sponsor: Revolution Medicines, Inc.. Phase: PHASE3. Conditions: Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma (PDAC), Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenocarcinoma, Pancreatic Adenosquamous Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06441435: The Effect of AC-134 in Chronic Kidney Diseases

    Sponsor: Taichung Veterans General Hospital. Phase: NA. Conditions: Nephrology

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06835725: Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prostate Cancer

    Sponsor: British Columbia Cancer Agency. Phase: PHASE2. Conditions: Prostate CA

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05739825: Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation

    Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: . Conditions: Clostridioides Difficile Infection Recurrence

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07215325: Got Doxy- 'Flipping the Script' on STI PEP

    Sponsor: Emory University. Phase: PHASE4. Conditions: Sexually Transmitted Infections (STI)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06044025: A Feasibility Study Evaluating a Role for Maintenance Therapy in Patients With Biochemically Progressive Castration Sensitive Prostate Cancer on Intermittent Androgen Deprivation Therapy

    Sponsor: University of Arkansas. Phase: PHASE1. Conditions: Castration Sensitive Prostate Cancer

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07471425: Survival Without Persistent Limiting Toxicity: Real Life Prospective Cohort of Advanced Neuroendocrine Tumor

    Sponsor: Gustave Roussy, Cancer Campus, Grand Paris. Phase: . Conditions: Neuroendocrine (NE) Tumors

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06800508: Primary and Secondary Stability of a One-Piece Compressive Implant System

    Sponsor: University of Sulaimani. Phase: . Conditions: Dental Implant

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT01617408: Brain Stimulation and Vision Testing

    Sponsor: National Institute of Mental Health (NIMH). Phase: . Conditions: fMRI, Dorsal Pathway, Ventral Pathway

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07680725: The Effect of Bottle PEP Exercise on Expiratory Muscle Thickness, Strength, and Balance Parameters in Parkinson's Disease Patients

    Sponsor: Marmara University. Phase: . Conditions: Parkinson Disease (PD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06532240: Methylene Blue for the Treatment of Septic Shock

    Sponsor: Northern Jiangsu People's Hospital. Phase: PHASE3. Conditions: Septic Shock

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07572240: A Clinical Trial to Assess the Effect of AP-Brain Collagen Peptides on the Improvement of Attention, Focus, and Memory in Stressed But Otherwise Healthy Individuals

    Sponsor: Rousselot BVBA. Phase: NA. Conditions: Healthy, Stress

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05945550: Comparison of Complication Rates Between Initial and Re-operative Anterior Lumbar Interbody Fusion Surgery: Is There a Difference?

    Sponsor: Methodist Health System. Phase: . Conditions: Lumbar Spondylolisthesis, Lumbar Spine Degeneration

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05816174: Longitudinal Study of Chronic Postsurgical Pain in Children and Adolescents

    Sponsor: Helen Koechlin. Phase: . Conditions: Chronic Post Operative Pain

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05540574: Trial of Zolpidem for Sleep in Children With Autism

    Sponsor: Stanford University. Phase: PHASE2. Conditions: Autism, Autism Spectrum Disorder

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05671874: Feasibility of a Digital Goals-of-Care Decision Aid for Clinicians and Families of Patients With SABI

    Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Hemorrhagic Stroke, Intracerebral, Acute Ischemic Stroke, Traumatic Brain Injury

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02905318: Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer

    Sponsor: Canadian Cancer Trials Group. Phase: PHASE2. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07477990: Clinical Trial to Evaluate the Efficacy and Safety of the Aurora® Digital Medical Device in Adult Patients With Moderate to Severe Generalized Anxiety Disorder

    Sponsor: Psicofarma, S.A. De C.V.. Phase: PHASE3. Conditions: General Anxiety Disorder

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07547397: COMPARISON OF CLASSICAL AND SYRINGE-FREE TECHNIQUES IN ULTRASOUND-GUIDED CENTRAL JUGULAR VENOUS CATHETERIZATION

    Sponsor: ALİEMAN. Phase: NA. Conditions: Central Venous Catheters/Standards, Ultrasonography/Methods, Ultrasonography/Standards

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07464197: Effectiveness of Dental Bleaching Using Different Designs of 3D-Printed and Conventional Customized Nightguards

    Sponsor: Universitat Internacional de Catalunya. Phase: NA. Conditions: Tooth Discoloration, Tooth Staining

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07341997: Environmental Factors Associated With Peripheral Neuropathies in French Guiana

    Sponsor: Admin CIC. Phase: NA. Conditions: Peripheral Neuropathies, Environmental Risk Factor, Lead Neuropathy, Mercury Neuropathy, Bita

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07188610: PA3-17 Injection in Adult Patients With CD7-positive Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma

    Sponsor: PersonGen BioTherapeutics (Suzhou) Co., Ltd.. Phase: PHASE2. Conditions: CD7-positive Relapsed/Refractory T Lymphoblastic Leukemia/Lymphoma

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT04132310: Mother Infant Nutrition Study

    Sponsor: University of Texas at Austin. Phase: . Conditions: Pregnancy Related, Infant Development

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07619560: Developing Precision Microbiota-Based Cocktail Modification Therapy to Delay the Progression of Parkinson's Disease (PD) - Use Preclinical Human Trials to Confirm the Impact of the Optimal "Probiotic Y7, Tryptophan and Branched-chain Amino Acid" Cocktail Formula on Early Stage PD Patients

    Sponsor: Taipei Medical University. Phase: NA. Conditions: Parkinson Disease (PD), Gut Microbiota, Probiotic

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07626320: Effectiveness of a Sound Bowl Meditation on Caregiver Stress and Anxiety

    Sponsor: Ohio State University. Phase: NA. Conditions: Stress, Anxiety

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06369220: A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

    Sponsor: Hoffmann-La Roche. Phase: NA. Conditions: Chlamydia Trachomatis Infection, Neisseria Gonorrhoeae Infection, Mycoplasma Genitalium Infection

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07661524: Passive Versus Active Music Therapy Parkinson's Disease

    Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Parkinson Disease (PD)

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06795282: Post Operative Sensitivity of MTA Obturation

    Sponsor: TC Erciyes University. Phase: . Conditions: Dental Pulp Disease, Endodontically Treated Teeth, Endodontic Disease

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07621224: Multimorbidity and Polypharmacy in People With HIV vs. the General Population in the Basque Country

    Sponsor: Biogipuzkoa Health Research Institute. Phase: . Conditions: HIV (Human Immunodeficiency Virus)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04091724: Perioperative EEG-Monitoring and Emergence Delirium in Children

    Sponsor: Huazhong University of Science and Technology. Phase: . Conditions: Delirium

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT06140823: Prospective Validation of Liver Cancer Risk Computation (LIRIC) Models

    Sponsor: Beth Israel Deaconess Medical Center. Phase: . Conditions: Predictive Cancer Model

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07327359: A Study to Evaluate Safety and Efficacy of OLX72021 in Healthy Males With Androgenetic Alopecia

    Sponsor: Olix Pharmaceuticals, Inc.. Phase: PHASE1. Conditions: Androgenetic Alopecia (AGA)

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07658859: Emotional Freedom Techniques in Nursing Students With Primary Dysmenorrhea

    Sponsor: Ataturk University. Phase: NA. Conditions: PRIMARY DYSMENORRHEA

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07298980: ExBRAC- Expressive Writing in Breast Cancer

    Sponsor: Region Skane. Phase: NA. Conditions: Breast Cancer

    full page →ctgov ↗
    ← prev
    page 81 of 98
    next →